We recently published Jim Cramer Took A Side On Biggest AI Debate & Discussed These 13 Stocks. NVIDIA Corporation (NASDAQ:NVDA) is one of the stocks discussed by Jim Cramer. AI GPU giant NVIDIA Corporation (NASDAQ:NVDA) reported its earnings on the 20th. By afternoon on the 21st, the shares were down by 1.43%. Cramer is one of the firm’s biggest fans. Ahead of the earnings, TD Cowen discussed the ...
We recently published Jim Cramer Took A Side On Biggest AI Debate & Discussed These 13 Stocks. NVIDIA Corporation (NASDAQ:NVDA) is one of the stocks discussed by Jim Cramer. AI GPU giant NVIDIA Corporation (NASDAQ:NVDA) reported its earnings on the 20th. By afternoon on the 21st, the shares were down by 1.43%. Cramer is one of the firm’s biggest fans. Ahead of the earnings, TD Cowen discussed the firm as it raised the share price target to $275 from $235 and kept a Buy rating on the 15th. The coverage came as the financial firm previewed the semiconductor earnings cycle and pointed out that investors were focused on stocks poised to benefit from shortages. Cramer discussed NVIDIA Corporation (NASDAQ:NVDA) ahead of the earnings report and asserted that CEO Jensen Huang would have to set the record straight about the competition his firm was facing from custom AI chips: “Yeah I’m not sure how much to rely on that because the narrative. . .reset by Jensen. And I think what he has to do is say that the total addressable market twice what people thought. And the thicket that he has to manage, Amazon and Alphabet. These are huge customers. They both on their conference call, do the, yeah NVIDIA’s important, we would never break up, but it’s our own chips, our own chips, our own chips. Andy Jassy, 50 billion dollar chip business. So what matters is, how much can he craft the story away from them, maybe using Anthropic, maybe using OpenAI, maybe using Meta, maybe using Elon. But David, you know that if he just goes in and doesn’t address the fact that these other guys are gunning for him, then I think [inaudible]. “. . .the fact is, Jensen is the best in the world, and if you bring yourself down, where you have to basically play defense, instead of offense, then I think people get confused. . .he’s gotta address the CPU issue, with Groq. And I think he can say, also, that people are misunderstanding the importance of these two hyperscalers. And that he can live without them...
The government plans to implement a law allowing terminally ill patients to refuse life-sustaining treatment from July 31, more than 20 months after the Legislative Council finally passed it. This has, wisely, allowed the healthcare sector time to prepare for important changes and for public education and awareness. The Advance Decision on Life-sustaining Treatment Ordinance provides legal status ...
The government plans to implement a law allowing terminally ill patients to refuse life-sustaining treatment from July 31, more than 20 months after the Legislative Council finally passed it. This has, wisely, allowed the healthcare sector time to prepare for important changes and for public education and awareness. The Advance Decision on Life-sustaining Treatment Ordinance provides legal status to patients’ advance-care planning while offering protection to healthcare and rescue personnel. Advance medical directives and do-not-attempt-cardiopulmonary-resuscitation (DNACPR) orders have been in place at public hospitals based on common law since 2010. As the new law takes effect, these two instruments will acquire formal statutory status. A lack of public awareness was cited as reason for the delay for almost 20 years. The law is therefore welcome and long overdue. It is needed to provide clarity and reassurance for patients, their families and medical and health professionals. Advertisement Awareness of advance directives has grown over the years. The Hospital Authority issued guidelines on their use in 2010, but more needed to be done. Although directives are covered by common law, the legal position needed to be clearer. Medical professionals could be unwilling to refrain from administering life-saving treatment and disputes could arise with family members. Advertisement
"I Think It Will Reduce Our Jobs": Jamie Dimon Predicts AI-Driven Workforce Shift At JPMorgan Artificial intelligence is set to significantly alter hiring patterns at JPMorgan Chase & Co., according to CEO Jamie Dimon, who said the bank expects to recruit more AI-focused talent while reducing reliance on some conventional banking roles over time, according to Bloomberg . During a Bloomberg Televis...
"I Think It Will Reduce Our Jobs": Jamie Dimon Predicts AI-Driven Workforce Shift At JPMorgan Artificial intelligence is set to significantly alter hiring patterns at JPMorgan Chase & Co., according to CEO Jamie Dimon, who said the bank expects to recruit more AI-focused talent while reducing reliance on some conventional banking roles over time, according to Bloomberg . During a Bloomberg Television interview at the firm’s China Summit in Shanghai, Dimon acknowledged the long-term impact AI is likely to have on employment across the industry. “I think it will reduce our jobs down the road,” he said. “There will be all different types of jobs, and I think we will be hiring more AI people and fewer bankers in certain categories, and it will make them more productive.” The shift reflects a broader transformation underway on Wall Street, where major banks are accelerating investments in automation and generative AI to streamline operations and improve efficiency. Executives across the sector have increasingly spoken about the technology’s ability to replace repetitive work while reshaping how financial institutions operate. Bloomberg writes that unlike some peers who have framed the transition more bluntly, Dimon emphasized that workforce reductions could largely happen gradually through attrition rather than mass layoffs. JPMorgan, which sees roughly 25,000 to 30,000 employees leave annually, has enough turnover to retrain or reposition workers as roles evolve, he said. He also argued that AI’s impact will not be limited to eliminating jobs. New positions are expected to emerge, particularly in areas tied to client relationships and revenue generation, even as some support and operational functions become more automated. Dimon’s remarks followed controversial comments from Standard Chartered CEO Bill Winters, who recently said the bank was replacing “lower-value human capital” with technology as part of a plan to cut thousands of support positions. Goldman Sachs Presi...
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. New federal ethics disclosures show President Donald Trump traded shares of Broadcom (NasdaqGS:AVGO) while in office. The trading involved Broadcom and other large technology stocks that were affected by U.S. policy and diplomatic decisions. The overlap betwee...
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. New federal ethics disclosures show President Donald Trump traded shares of Broadcom (NasdaqGS:AVGO) while in office. The trading involved Broadcom and other large technology stocks that were affected by U.S. policy and diplomatic decisions. The overlap between these trades and ongoing government actions has sparked fresh public and regulatory concern about potential conflicts of interest. For Broadcom, which last closed at $414.14, this development adds a political and regulatory angle to a story many investors mainly track through earnings, products and sector trends. The stock has had a very large 5 year return and is up 19.1% year to date, with a 1 year gain of 82.5%, even though it fell 2.6% over the past week and 2.0% over the past month. This unusual trading activity by a sitting president may influence how you think about risks around NasdaqGS:AVGO, especially where policy decisions and market moves intersect. The focus now is likely to be on how regulators, ethics bodies and market participants respond, and what that might mean for sentiment toward Broadcom and other large technology stocks linked to government actions. Stay updated on the most important news stories for Broadcom by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Broadcom. NasdaqGS:AVGO 1-Year Stock Price Chart See which insiders are buying and buying and selling Broadcom following this latest news. Quick Assessment ⚖️ Price vs Analyst Target : At US$414.14 versus a consensus target of about US$480.49, the stock sits roughly 14% below analyst expectations. ❌ Simply Wall St Valuation : Shares are trading about 27.3% above the Simply Wall St estimated fair value, which flags valuation risk. ❌ Recent Momentum: The stock has declined 2.0% over the past 30 days. To assess whether it may be the ri...
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Meta Platforms (NasdaqGS:META) has reached the first settlement with a U.S. school district over claims that its social media products harmed student mental health, in a case with more than 1,200 similar lawsuits pending. The Texas Attorney General has filed a new lawsuit accusing Met...
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Meta Platforms (NasdaqGS:META) has reached the first settlement with a U.S. school district over claims that its social media products harmed student mental health, in a case with more than 1,200 similar lawsuits pending. The Texas Attorney General has filed a new lawsuit accusing Meta of misleading consumers about WhatsApp’s encryption and privacy protections. A European court has ruled that Meta must compensate publishers for news snippets used on its platforms and for training its AI models. Meta Platforms, the owner of Facebook, Instagram and WhatsApp, sits at the center of how billions of people communicate and consume content. These legal developments affect core parts of that business, including youth engagement, messaging privacy, news distribution and AI training. For investors, the mix of U.S. and EU actions illustrates how regulatory and legal pressure can influence several key revenue and cost drivers at the same time. Ongoing lawsuits and rulings such as these may shape how Meta designs its products, prices its services and licenses content. As you assess NasdaqGS:META, it can be useful to monitor not only any settlement amounts, but also product changes, compliance commitments and content payment structures that emerge from these cases. Stay updated on the most important news stories for Meta Platforms by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Meta Platforms. NasdaqGS:META Earnings & Revenue Growth as at May 2026 📰 Beyond the headline: 1 risk and 4 things going right for Meta Platforms that every investor should see. Quick Assessment ✅ Price vs Analyst Target : The US$610.26 share price sits about 26% below the US$826.60 analyst target, with a target range of US$614 to US$1,015. ✅ Simply Wall St Valuation : Shares are described as trading 17.8% below estimated fair val...
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Meta Platforms (NasdaqGS:META) has reached the first settlement with a U.S. school district over claims that its social media products harmed student mental health, in a case with more than 1,200 similar lawsuits pending. The Texas Attorney General has filed a new lawsuit accusing Met...
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Meta Platforms (NasdaqGS:META) has reached the first settlement with a U.S. school district over claims that its social media products harmed student mental health, in a case with more than 1,200 similar lawsuits pending. The Texas Attorney General has filed a new lawsuit accusing Meta of misleading consumers about WhatsApp’s encryption and privacy protections. A European court has ruled that Meta must compensate publishers for news snippets used on its platforms and for training its AI models. Meta Platforms, the owner of Facebook, Instagram and WhatsApp, sits at the center of how billions of people communicate and consume content. These legal developments affect core parts of that business, including youth engagement, messaging privacy, news distribution and AI training. For investors, the mix of U.S. and EU actions illustrates how regulatory and legal pressure can influence several key revenue and cost drivers at the same time. Ongoing lawsuits and rulings such as these may shape how Meta designs its products, prices its services and licenses content. As you assess NasdaqGS:META, it can be useful to monitor not only any settlement amounts, but also product changes, compliance commitments and content payment structures that emerge from these cases. Stay updated on the most important news stories for Meta Platforms by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Meta Platforms. NasdaqGS:META Earnings & Revenue Growth as at May 2026 📰 Beyond the headline: 1 risk and 4 things going right for Meta Platforms that every investor should see. Quick Assessment ✅ Price vs Analyst Target : The US$610.26 share price sits about 26% below the US$826.60 analyst target, with a target range of US$614 to US$1,015. ✅ Simply Wall St Valuation : Shares are described as trading 17.8% below estimated fair val...
We recently published Jim Cramer Took A Side On Biggest AI Debate & Discussed These 13 Stocks. Intel Corporation (NASDAQ:INTC) is one of the stocks discussed by Jim Cramer. Chip manufacturing giant Intel Corporation (NASDAQ:INTC)’s shares are among the best performers in the market this year. They are up by a whopping 472% over the past year and by 200% year-to-date. Freedom Broker discussed Intel...
We recently published Jim Cramer Took A Side On Biggest AI Debate & Discussed These 13 Stocks. Intel Corporation (NASDAQ:INTC) is one of the stocks discussed by Jim Cramer. Chip manufacturing giant Intel Corporation (NASDAQ:INTC)’s shares are among the best performers in the market this year. They are up by a whopping 472% over the past year and by 200% year-to-date. Freedom Broker discussed Intel Corporation (NASDAQ:INTC) on April 28th as it upgraded the shares to Buy from Hold and bumped the share price target to $100 from $25. The financial firm remarked that the chip manufacturer’s first-quarter earnings report was a marker of the transition to a new thesis under CEO Lip-Bu Tan. Cramer also discussed Intel Corporation (NASDAQ:INTC)’s CEO: “Well that stock is going much higher, what can I say. I mean Lip-Bu, he’s the CPU guy, and the CPUs turned out to be far more important because of the agents. And all we hear about, agent, agent, agent. Well, David, agents are the future and Intel is where you get the chips for the agent. “Well what Lip-Bu was saying, the CEO of Intel, was look it’s the age, the intellectual property age of hardware. And the software has been, kind of, not wiped out, but the Anthropics, the OpenAIs, you can mimic a lot of stuff, better.” Jim Cramer Shares Key Insight For Intel's (INTC) Future Pixabay/Public Domain While we acknowledge the potential of INTC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Disclosure: None. Follow Insider Monkey on Google News.
We recently published Jim Cramer Took A Side On Biggest AI Debate & Discussed These 13 Stocks. Intel Corporation (NASDAQ:INTC) is one of the stocks discussed by Jim Cramer. Chip manufacturing giant Intel Corporation (NASDAQ:INTC)’s shares are among the best performers in the market this year. They are up by a whopping 472% over the past year and by 200% year-to-date. Freedom Broker discussed Intel...
We recently published Jim Cramer Took A Side On Biggest AI Debate & Discussed These 13 Stocks. Intel Corporation (NASDAQ:INTC) is one of the stocks discussed by Jim Cramer. Chip manufacturing giant Intel Corporation (NASDAQ:INTC)’s shares are among the best performers in the market this year. They are up by a whopping 472% over the past year and by 200% year-to-date. Freedom Broker discussed Intel Corporation (NASDAQ:INTC) on April 28th as it upgraded the shares to Buy from Hold and bumped the share price target to $100 from $25. The financial firm remarked that the chip manufacturer’s first-quarter earnings report was a marker of the transition to a new thesis under CEO Lip-Bu Tan. Cramer also discussed Intel Corporation (NASDAQ:INTC)’s CEO: “Well that stock is going much higher, what can I say. I mean Lip-Bu, he’s the CPU guy, and the CPUs turned out to be far more important because of the agents. And all we hear about, agent, agent, agent. Well, David, agents are the future and Intel is where you get the chips for the agent. “Well what Lip-Bu was saying, the CEO of Intel, was look it’s the age, the intellectual property age of hardware. And the software has been, kind of, not wiped out, but the Anthropics, the OpenAIs, you can mimic a lot of stuff, better.” Jim Cramer Shares Key Insight For Intel's (INTC) Future Pixabay/Public Domain While we acknowledge the potential of INTC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Disclosure: None. Follow Insider Monkey on Google News.
Construction cranes and an American flag outside of the White House in Washington, DC, US, on Thursday, April 16, 2026. Graeme Sloan | Bloomberg | Getty Images Law enforcement authorities are responding to shots that were fired near the White House grounds, FBI Director Kash Patel said. Journalists working there Saturday reported hearing a series of gunshots and were told to seek shelter inside th...
Construction cranes and an American flag outside of the White House in Washington, DC, US, on Thursday, April 16, 2026. Graeme Sloan | Bloomberg | Getty Images Law enforcement authorities are responding to shots that were fired near the White House grounds, FBI Director Kash Patel said. Journalists working there Saturday reported hearing a series of gunshots and were told to seek shelter inside the press briefing room, where U.S. Secret Service officers prevented them from leaving. There were no immediate reports of any injuries. On X, Secret Service said it was "aware of reports of shots fired near 17th Street and Pennsylvania Avenue NW" — one block from the White House — and was "working to corroborate the information with personnel on the ground." In a social media post, FBI Director Kash Patel said officers were responding to shots fired and said he would "update the public as we're able." President Donald Trump was inside the White House at the time. The Metropolitan Police Department did not immediately respond to requests for information. This story is developing. Please refresh for updates. Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
Africa’s top public health official said the latest Ebola outbreak in eastern Congo is being fought without one of the most important tools in epidemic response: vaccines. Jean Kaseya , Director-General of the Africa Centres for Disease Control and Prevention, said response efforts to the disease are now heavily dependent on community outreach and behavioral change campaigns to slow transmission. ...
Africa’s top public health official said the latest Ebola outbreak in eastern Congo is being fought without one of the most important tools in epidemic response: vaccines. Jean Kaseya , Director-General of the Africa Centres for Disease Control and Prevention, said response efforts to the disease are now heavily dependent on community outreach and behavioral change campaigns to slow transmission. The outbreak, now the “second largest” after the 2014-2016 West Africa epidemic, is caused by the rare Bundibugyo strain of the virus and has no approved vaccine or antibody treatment. Kaseya said hopes that existing vaccine options could provide even partial protection have faded in recent weeks. “It’s like you are a soldier,” he said in an interview. “You go to fight without ammunition. We have to rely on public health measures.” Kaseya said shortages extend far beyond vaccines and experimental treatments. Despite millions of dollars pledged by governments and aid agencies since the outbreak escalated, some frontline facilities are still struggling to secure basics, from personal protection equipment, known as PPE, to treatment space and laboratory supplies. “Why are we still lacking PPE?” he said, questioning where promised funding was going. In Bunia, not far from the Ugandan border, some patients were still being treated in ordinary hospital wards because dedicated Ebola treatment centers had not yet been fully established, he said. Health authorities are increasingly relying on local leaders and community networks to spread the word on safe practices including persuading families to modify long-held burial practices that can accelerate Ebola transmission. Tensions erupted near Bunia in Ituri province after relatives of a man who died at Rwampara Hospital clashed with health workers who refused to release his body because of infection risks. Ebola treatment tents run by aid group Alima were later set on fire during the unrest, and local reports said some patients fled ...